News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
448,194 Results
Type
Article (27720)
Company Profile (301)
Press Release (420173)
Multimedia
Podcasts (53)
Webinars (10)
Section
Business (125976)
Career Advice (301)
Deals (21027)
Drug Delivery (53)
Drug Development (64116)
Employer Resources (45)
FDA (8963)
Job Trends (7304)
News (218028)
Policy (17026)
Tag
Academia (1328)
Accelerated approval (5)
Adcomms (13)
Allergies (73)
Alliances (35354)
ALS (82)
Alzheimer's disease (997)
Antibody-drug conjugate (ADC) (125)
Approvals (8988)
Artificial intelligence (196)
Autoimmune disease (24)
Automation (11)
Bankruptcy (166)
Best Places to Work (6203)
BIOSECURE Act (6)
Biosimilars (54)
Biotechnology (247)
Bladder cancer (74)
Brain cancer (24)
Breast cancer (232)
Cancer (2000)
Cardiovascular disease (152)
Career advice (258)
Career pathing (4)
CAR-T (147)
Cell therapy (393)
Cervical cancer (13)
Clinical research (52166)
Collaboration (728)
Compensation (394)
Complete response letters (18)
COVID-19 (2180)
CRISPR (46)
C-suite (215)
Cystic fibrosis (90)
Data (1998)
Denatured (11)
Depression (36)
Diabetes (188)
Diagnostics (2965)
Digital health (10)
Diversity (2)
Diversity, equity & inclusion (12)
Drug discovery (99)
Drug pricing (42)
Drug shortages (8)
Duchenne muscular dystrophy (96)
Earnings (41594)
Editorial (25)
Employer branding (6)
Employer resources (42)
Events (80014)
Executive appointments (618)
FDA (10001)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (666)
Gene editing (110)
Generative AI (13)
Gene therapy (297)
GLP-1 (463)
Government (1994)
Grass and pollen (5)
Guidances (108)
Healthcare (9154)
Huntington's disease (23)
IgA nephropathy (28)
Immunology and inflammation (110)
Indications (25)
Infectious disease (2286)
Inflammatory bowel disease (132)
Inflation Reduction Act (8)
Influenza (41)
Intellectual property (80)
Interviews (48)
IPO (9695)
IRA (14)
Job creations (1549)
Job search strategy (238)
Kidney cancer (8)
Labor market (10)
Layoffs (260)
Leadership (3)
Legal (3367)
Liver cancer (54)
Lung cancer (279)
Lymphoma (149)
Machine learning (6)
Management (11)
Manufacturing (223)
MASH (68)
Medical device (4726)
Medtech (4727)
Mergers & acquisitions (11833)
Metabolic disorders (508)
Multiple sclerosis (71)
NASH (16)
Neurodegenerative disease (85)
Neuropsychiatric disorders (27)
Neuroscience (1480)
NextGen: Class of 2025 (2864)
Non-profit (1297)
Now hiring (22)
Obesity (250)
Opinion (179)
Ovarian cancer (74)
Pain (67)
Pancreatic cancer (71)
Parkinson's disease (140)
Partnered (12)
Patents (168)
Patient recruitment (98)
Peanut (41)
People (44962)
Pharmaceutical (50)
Pharmacy benefit managers (8)
Phase I (17455)
Phase II (23866)
Phase III (16049)
Pipeline (1168)
Policy (62)
Postmarket research (1500)
Preclinical (7241)
Press Release (40)
Prostate cancer (92)
Psychedelics (35)
Radiopharmaceuticals (223)
Rare diseases (346)
Real estate (2792)
Recruiting (19)
Regulatory (13199)
Reports (19)
Research institute (1280)
Resumes & cover letters (36)
Rett syndrome (4)
RNA editing (5)
RSV (28)
Schizophrenia (65)
Series A (115)
Series B (94)
Service/supplier (2)
Sickle cell disease (48)
Special edition (12)
Spinal muscular atrophy (126)
Sponsored (17)
Startups (2996)
State (1)
Stomach cancer (7)
Supply chain (43)
Tariffs (20)
The Weekly (41)
Vaccines (484)
Venture capitalists (35)
Weight loss (139)
Women's health (22)
Worklife (2)
Date
Today (36)
Last 7 days (769)
Last 30 days (2446)
Last 365 days (25337)
2025 (9474)
2024 (25882)
2023 (27431)
2022 (35027)
2021 (38117)
2020 (33281)
2019 (21716)
2018 (16096)
2017 (22103)
2016 (22759)
2015 (28107)
2014 (21392)
2013 (17607)
2012 (18078)
2011 (17822)
2010 (16311)
Location
Africa (368)
Alabama (46)
Alaska (2)
Arizona (107)
Arkansas (10)
Asia (27942)
Australia (4531)
California (5215)
Canada (1542)
China (435)
Colorado (201)
Connecticut (245)
Delaware (147)
Europe (64212)
Florida (667)
Georgia (157)
Idaho (26)
Illinois (414)
India (14)
Indiana (149)
Iowa (6)
Japan (137)
Kansas (80)
Kentucky (14)
Louisiana (4)
Maine (14)
Maryland (637)
Massachusetts (3993)
Michigan (111)
Minnesota (214)
Mississippi (1)
Missouri (51)
Montana (15)
Nebraska (6)
Nevada (46)
New Hampshire (23)
New Jersey (1434)
New Mexico (14)
New York (1458)
North Carolina (704)
North Dakota (7)
Northern California (2270)
Ohio (144)
Oklahoma (9)
Oregon (26)
Pennsylvania (969)
Puerto Rico (7)
Rhode Island (21)
South America (646)
South Carolina (8)
Southern California (2001)
Tennessee (50)
Texas (697)
United States (18305)
Utah (89)
Virginia (124)
Washington D.C. (45)
Washington State (456)
West Virginia (1)
Wisconsin (54)
448,194 Results for "amarna therapeutics b v".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Amarna Therapeutics Partners with NorthX Biologics to Advance Nimvec™ AM510 Gene Therapy Development
December 4, 2024
·
5 min read
Business
Amarna Therapeutics announces appointment of Aurelia Caparrós as new Chief Business Officer
Amarna Therapeutics, a privately-held biotechnology company developing transformative gene therapies in a range of rare and prevalent diseases, including Type 1 Diabetes Mellitus, announces the appointment of Aurelia Caparrós as the Company’s new Chief Business Officer, effective 1st of April 2024.
April 19, 2024
·
3 min read
Business
Amarna Therapeutics announces formation of Scientific Advisory Board to support advancement of groundbreaking Nimvec™ AM510 gene therapy against Type 1 Diabetes
Amarna Therapeutics, a privately-held biotechnology company focused on developing transformative gene therapies for a range of rare and prevalent genetic diseases, including Type 1 Diabetes Mellitus, is pleased to announce the formation of its new Scientific Advisory Board. The newly established SAB consists of seven distinguished international scientific opinion leaders.
June 17, 2024
·
7 min read
Press Releases
Phenocell and Amarna Therapeutics Awarded Eurostars Grant to Assess a Gene Therapy for Dry AMD using a novel 3-dimensional iPSC-derived Retinal Model of the Disease
December 11, 2024
·
4 min read
Press Releases
Amarna Therapeutics Receives Constructive Feedback from FDA INTERACT Meeting for AM510 Gene Therapy Development Targeting Type 1 Diabetes
August 27, 2024
·
3 min read
Press Releases
Vivoryon Therapeutics N.V. Signs Financing Agreement for up to EUR 15 Million
April 24, 2025
·
5 min read
Press Releases
NORDIC GROUP B.V. THROUGH ITS SUBSIDIARY NORDIC PHARMA, INC. (U.S.), ANNOUNCES LAUNCH OF AUTHORIZED GENERIC OF Maxitrol® (Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Suspension)
April 25, 2025
·
3 min read
Press Releases
Vivoryon Therapeutics N.V. Reports Full Year 2024 Financial Results and Provides Business Update
April 29, 2025
·
27 min read
Press Releases
Pharming Technologies B.V. increases its ownership in Abliva AB (publ) to 92.70 percent
February 21, 2025
·
11 min read
Deals
Clade Therapeutics Announces the Acquisition of Gadeta B.V.
Clade Therapeutics today announced that it has completed the acquisition of Gadeta B.V.
October 2, 2023
·
4 min read
1 of 44,820
Next
